Abstract
Diabetic retinopathy (DR) is the leading cause of blindness amongst the working-age population, and diabetes accelerated cardiovascular disease (CVD) the commonest cause of death in diabetic patients. Although, there is evidence suggesting a close association between DR and CVD, particularly in patients with Type 2 diabetes, the pathophysiology underlying the link is unclear. Here we review common risk factors and pathogenic mechanisms linking DR and CVD, and aim to highlight the need for a more holistic view of the management of diabetes and its complications. The understanding of the link between the two complications could eventually lead to refined management strategies and improved patient outcomes in the expanding diabetes epidemic.
Keywords: Diabetes, Diabetic retinopathy, Diabetes accelerated cardiovascular diseases, Common pathological pathways, Therapeutics, CVD, Atherosclerosis, pathogenic mechanisms, holistic view, diabetes epidemic.
Current Diabetes Reviews
Title:Diabetic Retinopathy and Atherosclerosis: is there a Link?
Volume: 9 Issue: 2
Author(s): Thomas Phillip Ellis, Ruhul Hassan Choudhury, Kirti Kaul, Mohit Chopra, Eva Maria Kohner, Joanna Mary Tarr and Rakesh Chibber
Affiliation:
Keywords: Diabetes, Diabetic retinopathy, Diabetes accelerated cardiovascular diseases, Common pathological pathways, Therapeutics, CVD, Atherosclerosis, pathogenic mechanisms, holistic view, diabetes epidemic.
Abstract: Diabetic retinopathy (DR) is the leading cause of blindness amongst the working-age population, and diabetes accelerated cardiovascular disease (CVD) the commonest cause of death in diabetic patients. Although, there is evidence suggesting a close association between DR and CVD, particularly in patients with Type 2 diabetes, the pathophysiology underlying the link is unclear. Here we review common risk factors and pathogenic mechanisms linking DR and CVD, and aim to highlight the need for a more holistic view of the management of diabetes and its complications. The understanding of the link between the two complications could eventually lead to refined management strategies and improved patient outcomes in the expanding diabetes epidemic.
Export Options
About this article
Cite this article as:
Ellis Phillip Thomas, Choudhury Hassan Ruhul, Kaul Kirti, Chopra Mohit, Kohner Maria Eva, Tarr Mary Joanna and Chibber Rakesh, Diabetic Retinopathy and Atherosclerosis: is there a Link?, Current Diabetes Reviews 2013; 9 (2) . https://dx.doi.org/10.2174/1573399811309020006
DOI https://dx.doi.org/10.2174/1573399811309020006 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Out-of-Hospital Cardiac Arrest –Optimal Management
Current Cardiology Reviews Research Advancements in Porcine Derived Mesenchymal Stem Cells
Current Stem Cell Research & Therapy A Clinical Perspective of Soluble Epoxide Hydrolase Inhibitors in Metabolic and Related Cardiovascular Diseases
Current Molecular Pharmacology Electrocardiographic Abnormalities in Thalassemia Patients with Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Pharmacological Approaches of Binge Drinking
Current Pharmaceutical Design Inflammatory Markers in Cardiovascular Disease; Lessons Learned and Future Perspectives
Current Vascular Pharmacology Dipeptidyl Peptidase IV Inhibitors: A New Paradigm in Type 2 Diabetes Treatment
Current Drug Targets Fluoride Interactions: From Molecules to Disease
Current Signal Transduction Therapy Patent Selections
Recent Patents on Cardiovascular Drug Discovery Hypoxia Inducible Factor-1α, Endothelial Progenitor Cells, Monocytes,Cardiovascular Risk, Wound Healing, Cobalt and Hydralazine:A Unifying Hypothesis
Current Drug Targets Epigenetic Modulation of Myocardial Angiogenic Balance: An Emerging Therapeutic Perspective for Adult Failing Heart
Current Angiogenesis (Discontinued) Patent Selections
Recent Patents on Cardiovascular Drug Discovery The Woman’s Heart: Insights into New Potential Targeted Therapy
Current Medicinal Chemistry Autonomic Nervous System in Viral Myocarditis: Pathophysiology and Therapy
Current Pharmaceutical Design Impacts of Nanoparticles on Cardiovascular Diseases: Modulating Metabolism and Function of Endothelial Cells
Current Drug Metabolism Triple Threat: The Na+/Ca2+ Exchanger in the Pathophysiology of Cardiac Arrhythmia, Ischemia and Heart Failure
Current Drug Targets Inflammatory Syndrome in Chronic Kidney Disease: Pathogenesis and Influence on Outcomes
Inflammation & Allergy - Drug Targets (Discontinued) Prediction of MicroRNA–disease Associations by Matrix Completion
Current Proteomics Algorithms and Criteria for Transcatheter Aortic Valve Replacement Patient Selection: Current Status and Future Trends
Current Pharmaceutical Design Meloxicam Prevents Load-Induced Cardiac Hypertrophy in Mice
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)